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Gene amplification as double minutes or homogeneously
staining regions in solid tumors: Origin and structure
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Domenico Trombetta,1 Pietro D’Addabbo,1 Giulia Daniele,1 Alberto L’Abbate,1
Gemma Macchia,1 Cecilia Surace,1,7 Klaas Kok,2 Reinhard Ullmann,3 Stefania Purgato,4
Orazio Palumbo,5 Massimo Carella,5 Peter F. Ambros,6 and Mariano Rocchi1,8
1Department of Genetics and Microbiology, University of Bari, Bari 70126, Italy; 2Department of Genetics, University Medical Centre
Groningen, University of Groningen, Groningen 9700 RR, The Netherlands; 3Department of Human Molecular Genetics, Max Planck
Institute for Molecular Genetics, Berlin 14195, Germany; 4Department of Biology, University of Bologna, Bologna 40126, Italy;
5Medical Genetics Unit, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 71013, Italy; 6Children’s Cancer
Research Institute (CCRI), St. Anna Kinderkrebsforschung, Vienna A-1090, Austria
Double minutes (dmin) and homogeneously staining regions (hsr) are the cytogenetic hallmarks of genomic amplification
in cancer. Different mechanisms have been proposed to explain their genesis. Recently, our group showed that the
MYC-containing dmin in leukemia cases arise by excision and amplification (episome model). In the present paper we
investigated 10 cell lines from solid tumors showing MYCN amplification as dmin or hsr. Particularly revealing results were
provided by the two subclones of the neuroblastoma cell line STA-NB-10, one showing dmin-only and the second hsr-only
amplification. Both subclones showed a deletion, at 2p24.3, whose extension matched the amplicon extension. Addi-
tionally, the amplicon structure of the dmin and hsr forms was identical. This strongly argues that the episome model,
already demonstrated in leukemias, applies to solid tumors as well, and that dmin and hsr are two faces of the same coin.
The organization of the duplicated segments varied from very simple (no apparent changes from the normal sequence) to
very complex. MYCN was always overexpressed (significantly overexpressed in three cases). The fusion junctions, always
mediated by nonhomologous end joining, occasionally juxtaposed truncated genes in the same transcriptional orientation.
Fusion transcripts involving NBAS (also known as NAG), FAM49A, BC035112 (also known as NCRNA00276), and SMC6 genes
were indeed detected, although their role in the context of the tumor is not clear.
[Supplemental material is available online at http://www.genome.org. Sequence data from this study have been sub-
mitted to GenBank (http://www.ncbi.nlm.nih.gov/genbank/) under accession nos. HM243501–HM243513, HM243515–
HM243529, and HM358636. NimbleGen array CGH data have been submitted to the NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/) under accession no. GSE22279. Affymetrix CGH data have been submitted to
ArrayExpress (http://www.ebi.ac.uk/microarray-as/ae/) under accession no. E-MEXP-2735.]
Overexpression of cellular oncogenes, a common theme in cancer,
can result from gene amplification through the formation of ex-
trachromosomal double minutes (dmin) or intrachromosomal
homogeneously staining regions (hsr). Their occurrence has been
more frequently reported in solid tumors compared with hema-
tological malignancies. Some oncogene amplifications are associ-
ated with specific tumors and usually represent an indicator of
poor prognosis (Albertson 2006; Myllykangas et al. 2007).
The breakage-fusion-bridge (BFB) cycle is one of the most
popular models invoked to explain intrachromosomal amplifica-
tion in solid tumors (Hellman et al. 2002; Selvarajah et al. 2006;
Reshmi et al. 2007; Vukovic et al. 2007). In thismodel, as originally
proposed by McClintock (1951), multiple cycles of BFB lead to the
amplification of genes near the breakage. This feature can be
regarded as a specific indication of BFB. A translocation-deletion-
amplification model has been also demonstrated in some tumors
(Barr et al. 1996; Roijer et al. 2002; Van Roy et al. 2006). In this
model, dmin or hsr derive from the breakpoint region of a trans-
location event. The ‘‘deletion-plus-episome’’ model, also known as
the ‘‘episome model,’’ postulates that a DNA segment is excised
from an otherwise intact chromosome, circularized, and amplified
by mutual recombination to produce dmin or hsr (Carroll et al.
1988). We have recently provided definitive evidence in favor of
the episome model for the formation of MYC-containing dmin in
acute myeloid leukemia (Storlazzi et al. 2006).
In this study we investigated the structure of MYCN amplifi-
cations, examples of both dmin and hsr, in eight neuroblastoma
(NB) and two small cell lung carcinoma (SCLC) cell lines.
Results
The 10 cell lines under study are reported in Table 1. Appropriate
fluorescence in situ hybridization (FISH) experiments disclosed
that in five cell lines MYCN was amplified as dmin, and in the
remaining five as hsr (Fig. 1; Table 1). TheMYCN gene was deleted
in one chromosome 2 homolog in both subclones of the STA-
NB-10 neuroblastoma cell line (Fig. 1). No MYCN deletion was
detected in the remaining cell lines, nor were rearrangements at
the MYCN locus noticed.
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Structure of amplicons
MYCN and the partially overlapping MYCNOS were the only genes
always involved in the amplification by oligo-array comparative
genomichybridization (CGH) analysis (NimbleGenwhole-genome,
385 K platform; average oligo distance ;6.3 kb; Supplemental
Figs. 1, 2). FISHwith fosmid and BACprobes (listed in Supplemental
Table 1) showed that a single hsr was present in two cell lines (SK-
N-BE and STA-NB-10/hsr), while two distinct hsr were present in
STA-NB-3, STA-NB-15, and GCL14 (Fig. 1). Some amplicons were
discontinuous, and the amplification levels of some segments were
remarkably different. Notably, in STA-NB-8, FISH provided a clear
confirmation of the heterogeneity of amplicon composition sug-
gested by the oligo-CGH analysis (example in Supplemental Fig. 3).
The amplicon structure of the two STA-NB-10 subclones was
identical in extent (chr2:15,510–18,630 kb; 3.12 Mb in size), and
the identical alternation of amplified and nonamplified segments
(Fig. 2) strongly suggested that they were the same amplification.
The nonamplified segments internal to the amplicon were shown
to be single copies (Fig. 2). All clones mapping inside the 3.12-Mb
amplicon of STA-NB-10 failed to yield signals on one chromosome
2 of both subclones (fluorescent in situ hybridization [FISH] ex-
amples in Fig. 3). They also failed to detect any signal, in STA-
NB-10/dmin, on chromosome 5q at the site of hsr insertion in STA-
NB-10/hsr (Fig. 1). Probes mapping at the boundary of this
amplicon defined the deletion as spanning, approximately, the
region chr2:15,483–18,575 kb (see Fig. 3 and legend).
Sequencing of junction regions
Breakpoint regions were refined by RQ-PCR experiments (Supple-
mental Table 2A) and by Affymetrix 6.0 SNP array (in STA-NB-8,
STA-NB-10/hsr, and STA-NB-15; see Supplemental Table 3). The
refinements allowed the setup of normal, long-range, or Vectorette
PCR experiments aimed at amplifying, cloning, and sequencing
the junction regions. When necessary, nested PCR assays were
designed to obtain short, ready-to-sequence amplification prod-
ucts. Thirty-two junctions were successfully sequenced (Supple-
mental Fig. 4; primers in Supplemental Table 2B) and allowed fine
characterization of the internal organization of the amplicons
(Fig. 4). The amplicon of the STA-NB-8 cell line was composed of
two fragments of different origin (chromosomes 2 and 8), arranged
‘‘head to tail.’’ The junction sequence resulting from the circular-
ization of the STA-NB-10/dmin amplicon (Junction I in Fig. 5)
defined its boundaries at the sequence level (chr2:15,481,998–
18,677,524; 3,195,526 bp in size). An identical junction sequence
was obtained from the STA-NB-10/hsr subclone. Additionally, all
the amplification products from the two subclones (about 30,many
of them spanning junction regions) yielded bands of identical size
(data not shown). Junctions III and VI of both subclones were suc-
cessfully sequenced and, again, they were identical (Fig. 5). Non-
amplified segments internal to the amplicon of the STA-NB-10/hsr,
already shown to be single-copy (see above), were found to be ho-
mozygous for all the analyzed SNPs (Affymetrix 6.0 SNP array;
Supplemental Table 4). Supplemental Figure 5 graphically summa-
rizes the different potential steps of gene amplification in the cell
lines, constructed according to the collected data. A bioinformatic
analysis of all amplicon breakpoints is reported in the Supplemental
material. The analysis did not disclose noteworthy results.
Mapping of hsr insertion sites
All hsr were inserted in chromosomes other than chromosome 2,
with the exception of STA-NB-3, in which the hsr mapped on
















(NB) Neuroblastoma, (SCLC) small cell lung carcinoma.
Figure 1. Partial metaphases showing cohybridization FISH experi-
ments using WCP specific for chromosome 2 (green) and RP11-480N14
(chr2:15,999,497–16,004,580), containing the MYCN gene (red). GLC8,
STA-NB-4, STA-NB-8, STA-NB-10/dmin, and STA-NB-13 showed MYCN
amplification in form of dmin (example provided at right). The remaining
cell lines displayed hsr amplification in a single location (SK-N-BE, STA-NB-
10/hsr) or in multiple locations (GLC14, STA-NB-3, STA-NB-15). Note the
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chromosome2, but far away (;61Mb) from theMYCN locus (2p12;
MYCN is at 2p24.3) (Supplemental Fig. 6). On visual inspection,
hsr could be classified as high- (Fig. 6a–c) or low-copy-number
(Fig. 6d–f). Occasionally, two different levels of hsr amplification
were found in the same cell line, as in STA-NB-3 (Fig. 6a,d).
Gajduskova et al. (2007) speculated on the influence of genome
position on the level of amplification of the inserted sequences.
To investigate this, iterative cohybridization FISH experiments
were performed to define the hsr insertion sites (see Supple-
mental Table 5). The most informative experiments are reported
in Figure 6 and in Table 2. We did not detect deletions at the
insertion sites, within the limits of FISH resolution.
Fusion genes generated by junctions
Fusion genes are of relevance in cancer (Mitelman et al. 2004). In
this study we found several junctions juxtaposing truncated genes
in the same transcriptional orientation (see Supplemental mate-
rial). Reverse transcriptase (RT)-PCR analysis, performed to reveal
fusion transcripts, detected two distinct 59NBAS/39BC035112 (NBAS
also known asNAG; BC035112 also known asNCRNA00276) short
chimeric transcripts in cell lines GLC8 and STA-NB-3 (details in
Supplemental Fig. 7) that, in silico, did not detect any chimeric
NBAS/BC035112 protein (data not shown). In cell line STA-NB-4
we detected another in-frame fusion transcript involving theNBAS
gene, composed of the 59 of NBAS, from exons 13–42 (exon 35 is
spliced out), and the 39 of FAM49A, exons 3–12 (Supplemental
Fig. 6). The transcript was predicted to encode a NBAS/FAM49A
chimeric protein of 1511 amino acids, fusing 1185 amino acids of
NBAS, containing its Sec39 domain, to 326 amino acids of the
FAM49Aprotein (secretory pathway) (data not shown). In STA-NB-
10 subclones we detected a fusion transcript composed of the 59 of
FAM49A (exon 1 only) and the 39 of SMC6 (exons 5–13) (accession
no. AK292421). This transcript did not encode a chimeric protein,
butwould encode a 315-amino-acidORF starting at a codonwithin
exon 5 of SMC6, containing a P-loop NTPase superfamily domain.
Gene expression analysis
Amplicons of the different cell lines showed large size variability,
and several genes were coamplified with MYCN (Supplemental
Table 6; Supplemental Fig. 8). We in-
vestigated their expression pattern by
RQ-PCR (primers reported in Supple-
mental Table 7). MYCN, amplified in all
cell lines, turned out to be always overex-
pressed, although the increase of tran-
scriptional level was statistically signifi-
cant only in three NB cell lines (STA-NB-8,
STAN-B10, and SK-N-BE). MYCNOS was
the only gene always coamplified with
MYCN (see Discussion). Expression data of
genes with known function are reported
in detail in Supplemental Figure 9 and
Supplemental Table 8. The overall results
indicated that, in addition toMYCN, only
GREB1 in STA-NB-8 and RAD51AP2 and
SMC6 in STA-NB-10 were significantly
overexpressed. Surprisingly, two genes
(VSNL1 and GEN1 in STA-NB-10) dis-
played significant down-regulation de-
spite the gain of copy number. VSNL1
was significantly down-regulated also in
all NB cell lines analyzed (Supplemental Table 8). RQ-PCR ex-
periments were also performed to test the expression of genes
interrupted by hsr insertions. The results are described in the Sup-
plemental material and summarized in Supplemental Figure 10 and
Supplemental Table 9.
Bioinformatic analysis of hsr insertions
Each hsr insertion site, 400 kb on both sides, was carefully inspec-
ted to search for features either shared by all insertion sites or which
would allow a differentiation of high- versus low-copy-number hsr
(see Supplemental Tables 10–16). The search did not identify any
shared features.
Discussion
In the present paper we characterized the structure of MYCN
amplicons present, in the form of dmin or hsr, in eight NB and two
SCLC cell lines. The most interesting result was represented by the
perfect matching, in both STA-NB-10 subclones, of the amplicon
extension with the extension of the deletion, defined by FISH,
found on one chromosome 2. The episomal model has already
been hypothesized in solid tumors (Carroll et al. 1988; Corvi et al.
1995). Our finding provided strong evidence of it.
A second revealing result of the present study is the strikingly
identical structure of dmin and hsr amplicons of the two STA-
NB-10 subclones. This finding suggests that the hsr has evolved
from the dmin, as graphically reported in Supplemental Figure 5B.
The steps can be summarized as follows: excision, circularization,
substantial internal reorganization, amplification, and, in hsr
cases, chromosomal integration and further amplification. Theo-
retically, it can be hypothesized that the excised DNA segment was
inserted and amplified as an hsr first. Then, in STA-NB-10/dmin,
the hsr extruded to form dmin. The absence, in STA-NB-10/dmin,
of any FISH signal at 5q in experiments using probes mapping
within the amplicon, and the absence, in STA-NB-10/hsr, of any 5q
amplification (CGH array data) imply a perfect and complete ex-
trusion of the hsr to form dmin, which seems unlikely. On the
other hand, if hsr represents a potential evolution of dmin, one
could expect the simultaneous presence of dmin andhsr in cases in
Figure 2. Details of array CGH data (chr2:14,500,000–19,500,000) related to both STA-NB-10/dmin
(triangles) and STA-NB-10/hsr (circles) subclones. The pattern of amplified/nonamplified regions perfectly
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which hsr were formed. Some examples of such cases have been
reported (Fegan et al. 1995; Yoshimoto et al. 1999; Roijer et al.
2002). It has to be considered, however, that dmin are per se un-
stable structures. They can be eliminated spontaneously or after
addition of certain drugs such as hydroxyurea (Ambros et al. 1997;
Narath et al. 2007; Shimizu et al. 2007). Their retention in tumor
cells is, very likely, under strong selective pressure, as it has been
demonstrated for dihydrofolate reductase dmin originated in re-
sponse to methotrexate treatment (Martinsson et al. 1982). The
selective pressure on dmin, presumably, rapidly drops when an
hsr is formed, the latter being intrinsically more stable, and the
cell population will soon be composed of a mosaic of dmin- and
Figure 3. Definition of the boundaries of the deletion on chromosome 2 present in the cell line STA-NB-10/dmin using FISH. (a,b) Partial metaphases
showing examples of FISH experiments using fosmid probes spanning the distal (a) and proximal (b) breakpoints of the deleted region, cohybridized with
the BAC containing the MYCN gene. (c,d ) The position on the human sequence of fosmid clones in a and b, respectively. (Vertical red lines) Amplicon
boundaries that were defined by sequencing the amplicon junction (see text and Supplemental Fig. 4). The definition of the deletion breakpoints was
obtained as follows. Distal breakpoint. Fosmid G248P87145E2 (chr2:15,461,044–15,505,473; 44.4 kb) gave a signal on del(2) that, by eye, consistently
appeared to be half the intensity of the signal on normal chromosome 2 (10 analyzedmetaphases; its black and white original signal is separately reported
in a). The middle part of the fosmid was therefore assumed to harbor the telomeric break of the deletion at ;chr2:15,483 kb. G248P87145E2 is present
also on the amplicon (a, inset), but the signal intensity is biased by the amplification. The normal intensity on del(2) of fosmid G248P800648F12
(chr2:15,428,940–15,471,782), and the absence of any signal on the dmin, was consistent with the assumption in a. Proximal breakpoint. Fosmid
G248P87325H8 (chr2:18,656,707–18,695,100; 38.4 kb) consistently gave a signal of half intensity on del(2) (10 analyzedmetaphases; its black andwhite
original signal is separately reported in b). The centromeric break of the deletion was therefore assumed to lay at;chr2:18,575 kb. Note that sequences of
G248P87145E2 are present on the amplicon (b, inset), but, again, the signal intensity is biased by the amplification. The intensity on del(2) of signals
yielded by fosmids G248P89303A7, G248P85351E4, and G248P86949C3 was consistent with this hypothesis. The deletion, therefore, spanned ap-
proximately the interval chr2:15,483–18,575 kb. Because of growth difficulty of the STA-NB-10/hsr cell line, not all FISH experiments performed on
STA-NB-10/dmin were also performed in hsr subclone (see Supplemental Table 1). (e,f ) Evidence for the deletion on one of the two copies of chromosome
2. Two fosmid clones flanking the deleted region (red andgreen)were hybridizedwith a probe (RP11-723P4, violet)mappingwithin the deletion but absent
in the amplicon (see text). The BAC was chosen in order to avoid the high background due to the amplification. The distance between the red and green
probes on normal chromosome 2 (red arrow) is substantially reduced on the del(2) (white arrow), as expected. (f ) Rationale of the FISH experiment in e.
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hsr-only cells (see Balaban-Malenbaum and Gilbert 1977; Yoshida
et al. 1999). The complete loss of dmin can follow. The patient
reported by Yoshida et al. (1999) initially showed a hsr/dmin
mosaic, then, after therapy, only hsr cells were found. Similar re-
sults have been observed also in cultured tumor cells (Quinn et al.
1979; George and Francke 1980; George and Powers 1982). The
view that hsr are the result of dmin integration is not new
(Coquelle et al. 1998; Bignell et al. 2007; Campbell et al. 2008). Our
results on STA-NB-10 subclones add strong support for this view.
STA-NB-10 was the only cell line showing the deletion event.
When the excision is postreplicative, the amplified episome, likely
conferring a growth advantage, may segregate with either the
normal or the deleted chromatid. The deletion, therefore, is not
a necessary occurrence. On average, however, it should be found in
;50% of postreplicative cases, and up to 100% of non-post-
replicative cases. In our recent work on gene amplification in he-
matological malignancies, the deletion was detected in 68% (23
out of 34) of the studied cases (Storlazzi et al. 2006). It is unclear
why, in the present study, no cell line other than STA-NB-10
showed the deletion. It is worth noting,
however, that, as far aswe know, deletions
not accompanied by more complex chro-
mosomal events, and corresponding to
the amplified sequences, have been re-
ported in solid tumors only by Gibaud
et al. (2010).
Amplicon structure
GLC14, SK-N-BE, and STA-NB-4 cell lines
showed an amplicon composed of a single
fragment; i.e., the excised segment did not
undergo internal rearrangement before
amplification. The remaining amplicons
showed a more complex structure, com-
posed of noncontinuous, non-colinear
segments often fused in opposite orienta-
tion (Fig. 4). The STA-NB-8 amplicon dis-
closed coamplification with a sequence
from the long arm of chromosome 8
(Fig. 4; Supplemental Fig. 3). Array-CGH
analysis disclosed an additional type of
complexity. The level of amplification of
the different fragments was occasionally
substantially different (see STA-NB-8 in
Supplemental Fig. 2). Such differences
were noted in both dmin and hsr. These
findings clearly indicated that these
amplicons were heterogeneous and that
some events affecting the structure of
the amplicon occurred at later stages with
respect to the excision event. This het-
erogeneity has also been reported by
Campbell et al. (2008), who assumed that
the most frequent rearrangements, esti-
mated by copy-number analysis, occurred
early. The FISH experiments on line STA-
NB-8, reported in Supplemental Figure
3A, clearly documented a mosaicism. The
power of FISH in detecting sequence
stretches less than ;10 kb in size, how-
ever, is relatively low, and we can sup-
pose that the heterogeneity could be higher than suspected.
Changes of the amplicon structure could occur at any time dur-
ing proliferation.
STA-NB-3, STA-NB-13, and STA-NB-15 cell lines showed coam-
plification of segments located >5Mb apart fromMYCN (up to 55Mb
apart in STA-NB-13) (Fig. 4); in STA-NB-8 the nonsyntenic coampli-
fication involved a;4-kb DNA stretch located at chr8:142,896,365–
142,982,315. These findings suggest that the event that originated
the amplicon patchwork was a complex rearrangement in which
more than one chromosomal domain participated (Supplemental
Fig. 5). The occurrence of coamplification of genes originating from
different chromosomes is not a rare event in hematological amplifi-
cations (Frascella et al. 2000; Morel et al. 2003; Graux et al. 2004;
Martin-Subero et al. 2005; Van Roy et al. 2006). Amplicons with
a complex pattern have been reported also in studies utilizing fresh
cancermaterial and analyzed using array-CGH technology (Beheshti
et al. 2003;Caren et al. 2008; Fix et al. 2008; Stock et al. 2008).Gibaud
et al. (2010) documented, in a glioma case, dmin derived from four
different chromosomal domains.
Figure 4. (Lower part of each section) Schematic representation of the structure of the amplicon.
Different blocks composing the amplicons are represented by arrows of different color. (Upper parts)
Arrangement of the amplified blocks in the reference sequence (hg18). (Gray line segments) Non-
amplified regions; (vertical figures) boundaries of the breaks, at single-base resolution if sequenced
(Supplemental Fig. 4), or as a small interval (maximum interval size: 2.5 kb); (?) uncloned fusion regions.
In STA-NB-10 the deleted regions (del) internal to the amplified region are indicated. The lengths of the
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The sequencing of 32 amplicon junctions disclosed 11
microhomologies and 12 anonymous insertions, typical of
nonhomologous end joining. Campbell et al. (2008) detected
microhomologies in 53% of the joined ends of the acquired rear-
rangements. Genomic structure, such as segmental duplications, has
been shown to affect specific rearrangements in tumors (Barbouti
et al. 2004). More specifically, Gibcus et al. (2007) have reported, in
their study of 30 patients and eight cell lines showing 11q13 am-
plification, that amplified regions are flanked by segmental dupli-
cations, suggested to play an important role in triggering the initial
rearrangement. Many of these amplifications, however, were hy-
pothesized to arise though the BFB mechanism. We did not find
any fusion junction joining sequences with high similarity, in-
dicating that, in our cases, mechanisms mimicking nonallelic ho-
mologous recombination did not play a role in the genesis of the
rearrangements.
The common fragile site FRA2C maps at the band 2p24.2,
which encompasses the region chr2:17,000,001–19,100,000, rela-
tively close to the MYCN gene (chr2:15,999,497–16,004,580). Some
breakpoints (the proximal breakpoint of the STA-NB-10 amplicon,
for instance, chr2: 18,677,524) map at 2p24.2. FRA2C, however, was
not preciselymapped at sequence level. It is therefore premature to
establish a correlation between the FRA2C and excision events.
Recently, the somatically acquired rearrangements of some
tumor cell lines showing gene amplification (NCI-H1770 cell line in
particular, containing amplified copies of MYCN) were investigated
by end-sequencing of BAC libraries (Bignell et al. 2007) or by ana-
lyzing the end-pairs of short DNA fragments obtained by massive
sequencing (Campbell et al. 2008). These studies have the advantage
of a precise, genome-wide detection of almost all changes, including
those that were acquired in late passages of the cell line, which were
probably missed in our study. Very likely, we detected only the more
common ones that, on the other hand, are presumably the more an-
cestral and more relevant ones, as stressed by Campbell et al. (2008).
Expression of amplified genes,
interrupted genes, and fusion genes
MYCN was overexpressed in all cell lines.
However the overexpression level reached
significance only in three cell lines (Sup-
plemental Table 8A,B). However, there is
no doubt that MYCN is the target gene of
amplifications of the 2p4.3 domain pres-
ent in all dmin and hsr amplicons. Ampli-
con erosion can lead to tumor cell rever-
tance and tumor cell senescence in vitro
(Ambros et al. 1997; Narath et al. 2007).
The MYCNOS gene partially overlaps with
MYCN because it lies on the opposite
strand (Armstrong and Krystal 1992).
This gene, therefore, was always present
in amplicons (Supplemental Table 8A), as
reported in similar studies (Scott et al.
2003; Caren et al. 2008; Fix et al. 2008).
MYCN and MYCNOS are unique in that
they are coregulated in tumor cell lines
under basal growth conditions and in
response to the differentiating agent ret-
inoic acid (Armstrong and Krystal 1992).
We extended the expression analysis to
genes whose function was known. Some
genes, such as GREB1 in STA-NB-10,
known to be involved in cancer (Sun et al. 2007), or GEN1 in STA-
NB-8, appeared overexpressed although not amplified (Supple-
mental Table 8A). The present data also indicated that some genes
(such as VSNL1 in NB cell lines, and PQLC3 in both SCLC and NB
cell lines) are consistently down-regulated regardless of their
amplification status. VSNL1 down-regulation has been already
reported in squamous carcinoma cells (Gonzalez Guerrico et al.
2005) and in non-small cell lung carcinomas (Fu et al. 2008). Our
data suggest that it may have a tumor suppressor role also in NB
tumors. The role, in cancer, of PQLC3, encoding an integral
membrane protein, is presently unknown. Again, its down-regu-
lation in both NB and SCLC tumors may indicate a putative
function as a tumor suppressor gene.
Our analysis of the junction points at the sequence level
identified four potential fusion genes. For all of them we were able
to detect a transcript, and one predicted chimeric protein was
identified (NBAS/FAM49A). We did not detect a chimeric protein
for the other fusion genes. However, these findings do not exclude
a role of a transcript in tumorigenesis (Guastadisegni et al. 2008).
Methods
All sequence data refer to the human genome assembly hg18,
March 2006 release.
Cell lines
Cell lines, as an alternative to primary tumors, have been chosen in
order to have a higher availability of material to perform the
present study. The cell lines investigated are listed in Table 1. SCLC
cell lines GLC8 and GLC14 were obtained as previously described
(van der Hout et al. 1989) and provided by K. Kok. The NB cell line
SK-N-BE (Biedler and Spengler 1976)was provided byG.Della Valle
(University of Bologna, Italy). STA-NB cell lines were provided by
Figure 5. Sequence of Junctions I, III, and VI of STA-NB-10/dmin and STA-NB-10/hsr (see Fig. 4),
found identical at the single base-pair level. Note the AT microhomology at the junction.
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P.F. Ambros, and some of them have been previously described
(Ambros et al. 1997; Narath et al. 2007; Stock et al. 2008). STA-NB-
10/hsr and STA-NB-10/dmin are subclones of the same cell line,
showing MYCN [v-myc myelocytomatosis viral related oncogene,
neuroblastoma derived (avian)] amplification in form of hsr or
dmin, respectively.
FISH, multicolor-FISH, long-range PCR, Vectorette PCR,
sequencing, and RQ-PCR were performed as already described
(Storlazzi et al. 2006).
Oligo-array CGH
Whole-genome CGH array analysis was performed to define DNA
copy number gains and losses. DNAwas extracted from tumor cell
lines using standard methods. Tumor DNAs and a NimbleGen
human reference sample were labeled and cohybridized on a high-
resolution NimbleGen 385 K Whole-Genome Tiling array (build
hg18; NCBI Build 36), which has a median probe spacing of 6270
bp. DNA copy number gains and losses were viewed using Roche
NimbleGen’s SignalMap software. DNA segmentation analysis has
been performed using the circular binary segmentation algorithm
from Olshen et al. (2004).
Single nucleotide polymorphism (SNP) array CGH
A whole-genome SNP array analysis was performed on STA-NB-8,
STA-NB-10/hsr, and STA-NB-15 cell lines using the Affymetrix
Genome Wide Human SNP Array 6.0, including over 906,600
single nucleotide polymorphisms (SNPs) and more than 946,000
probes for the detection of copy number variation. Sample prep-
aration, hybridization, and scanning were performed using
GeneChip Instrument System hardware according to the manu-
facturer’s specifications (Affymetrix). Quality controls and LOH
analysis have been performed using Affymetrix Genotyping
Console Software. Copy Number Variant segments have been
produced with Partek Genomic Suite Software (Partek Inc.), per-
forming an unpaired analysis using as baseline the 270 HapMap
samples and hidden Markov model method.
Gene expression quantification
Gene expression level was determined by RQ-PCR. The cDNA was
obtained using theQuantiTect Reverse TranscriptionKit (QIAGEN)
according to the handbook protocol. The cDNA was amplified
using the Applied Biosystems Real-Time PCR System 7300 in the
presence of SYBR Green I. The optimization of the RQ-PCR re-
actionwas performed according to themanufacturer’s instructions
(Applied Biosystems) but scaled down to 10 mL per reaction. In-
dividual Real-Time PCR was performed in a 96-well plate (Applied
Biosystems) containing 13 Platinum SYBRGreen qPCR SuperMix-
UDGwith ROX (Invitrogen), 500 nM ROX Reference (Invitrogen),
and 300 nM of sense and antisense primers. All measurements
were performed at least in triplicate.
The PCR conditions were as follows: 2 min at 50°C, 10 min at
95°C, followed by 40 cycles of 15 sec at 95°C and 1min at 60°C for
all the primer pairs used. At the end of each reaction, the cycle
threshold (Ct) was manually set up at a level that reflects the best
kinetic PCR parameters. Primers were designed with an internet-
based interface, Primer3 (Rozen and Skaletsky 2000).
The primers were checked for specificity using the BLAT tool
in the UCSC Human Genome Browser (http://genome.ucsc.edu/
cgi-bin/hgBlat).
In order to improve the normalization step, 10 housekeeping
genes were tested (ACTB, B2M, GAPDH, HMBS, HPRT1, RPL13A,
SDHA, RN28S1, UBC, and YWHAZ ) and the three best-performing
housekeeping genes (HPRT1, SDHA, and UBC), selected by apply-
ing the geNorm software (Vandesompele et al. 2002), were used.
For accurate averaging of the control genes, we used the geometric
mean, instead of the arithmetic mean, and the normalized gene of
interest (GOI) expression levels were calculated by dividing the
raw GOI quantities for each sample by the appropriate geometric
mean. We used total brain RNA (Clontech Laboratories, Inc.) and
a pool of three normal lung RNA samples as calibrators for NB and
SCLC cell lines, respectively.
Finally, statistical significance analysis of data was performed
using the Relative expression software tool (REST) (Pfaffl et al. 2002).
Detection of fusion transcripts
RT-PCR experiments were performed in order to detect the occur-
rence of fusion transcripts, generated by the expression of chimeric
genes at amplicon junctions, in cell lines STA-NB-3, STA-NB-4, STA-
NB-10, and GLC8. In STA-NB-3 and GLC8, a primer combination
of a forward primer specific for exon 41 of NBAS with a reverse
primer for exon 3 of BC035112 was used. In STA-NB-4, the same
NBAS forward primer was placed in combination with a reverse
primer for exon 7 of FAM49A. In STA-NB-10, a FAM49A exon 1
forward primer was used in combination with a SMC6 exon 7 re-
verse primer. Fusion products were sequenced and analyzed by
Figure 6. Cohybridization FISH experiments used to characterize hsr
insertion sites. MYCN was used in all experiments to mark the hsr, and it
was cohybridized with contiguous probes flanking the insertion (a,f ) or
with clones yielding split signals (b–e). (a) In STA-NB-3, the insertion is
within the short arm of chromosome 13, between the centromere
(alphoid probe, red) and the NOR region (RP5-1174A5). (c) In STA-NB-15,
the BAC RP11-449J21 (red) displayed signals distally, proximally, and
within the hsr (arrowheads), likely due to a duplication event occurring
simultaneously to the hsr insertion process. (e,f ) Cell line GLC14 showed
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BLAST. In silico translation of the full-length chimeric transcripts
was performed using the ORFfinder Tool of the NCBI website
(http://blast.ncbi.nlm.nih.gov).
Bioinformatic analysis
The ‘‘Self Chain,’’ ‘‘Repeat Masker,’’ ‘‘RefSeq Genes,’’ ‘‘Segmental
Duplication,’’ and ‘‘Structural Variation’’ tracks of the UCSC Ge-
nome Browser (http://genome.ucsc.edu/cgi-bin/hgTables) were
carefully inspected. Additional bioinformatic analysis was lo-
cally performed using the Fuzznuc algorithm (http://bioweb2.
pasteur.fr/docs/EMBOSS/fuzznuc.html). The 400-kb regions span-
ning each breakpoint (Supplemental Table 10) were searched
for consensus sequences, in order to disclose the frequency of
motifs known to be involved in chromosome instability (Supple-
mental Table 11). Detectedmotifs are listed in Supplemental Tables
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